SAGA Fundamental Analysis - SAGA PURE ASA

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to SAGA. SAGA was compared to 58 industry peers in the Financial Services industry. No worries on liquidiy or solvency for SAGA as it has an excellent financial health rating, but there are worries on the profitability. SAGA is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year SAGA has reported negative net income.

In the past year SAGA had a positive cash flow from operations.

In multiple years SAGA reported negative net income over the last 5 years.

In multiple years SAGA reported negative operating cash flow during the last 5 years.

1.2 Ratios

The Return On Assets of SAGA (-0.64%) is worse than 72.41% of its industry peers.

With a Return On Equity value of -0.69%, SAGA is not doing good in the industry: 65.52% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-0.64%
ROE	-0.69%
ROIC	N/A

ROA(3y)-5.91%

ROA(5y)5.15%

ROE(3y)-5.95%

ROE(5y)5.23%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

In the last couple of years the Operating Margin of SAGA has grown nicely.

SAGA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3Y28.87%

OM growth 5Y16.16%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

SAGA has about the same amout of shares outstanding than it did 1 year ago.

The number of shares outstanding for SAGA has been increased compared to 5 years ago.

There is no outstanding debt for SAGA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

SAGA has an Altman-Z score of 8.50. This indicates that SAGA is financially healthy and has little risk of bankruptcy at the moment.

The Altman-Z score of SAGA (8.50) is better than 89.66% of its industry peers.

The Debt to FCF ratio of SAGA is 0.89, which is an excellent value as it means it would take SAGA, only 0.89 years of fcf income to pay off all of its debts.

Looking at the Debt to FCF ratio, with a value of 0.89, SAGA belongs to the top of the industry, outperforming 87.93% of the companies in the same industry.

A Debt/Equity ratio of 0.03 indicates that SAGA is not too dependend on debt financing.

SAGA has a better Debt to Equity ratio (0.03) than 87.93% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.03
Debt/FCF	0.89
Altman-Z	8.5

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

SAGA has a Current Ratio of 131.70. This indicates that SAGA is financially healthy and has no problem in meeting its short term obligations.

Looking at the Current ratio, with a value of 131.70, SAGA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.

A Quick Ratio of 131.70 indicates that SAGA has no problem at all paying its short term obligations.

With an excellent Quick ratio value of 131.70, SAGA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	131.7
Quick Ratio	131.7

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

SAGA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -161.27%.

Measured over the past years, SAGA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -48.62% on average per year.

Looking at the last year, SAGA shows a very negative growth in Revenue. The Revenue has decreased by -239.11% in the last year.

EPS 1Y (TTM)-161.27%

EPS 3Y-76.41%

EPS 5Y-48.62%

EPS Q2Q%-429.68%

Revenue 1Y (TTM)-239.11%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%-1234.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

SAGA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of SAGA indicates a slightly more expensive valuation: SAGA is more expensive than 67.24% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	39.75
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for SAGA!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

SAGA PURE ASA

OSL:SAGA (1/9/2026, 7:00:00 PM)

1.49

-0.01 (-0.33%)

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupFinancial Services

GICS IndustryFinancial Services

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners0.75%

Inst Owner ChangeN/A

Ins Owners19.85%

Ins Owner ChangeN/A

Market Cap1.01B

Revenue(TTM)-50.70M

Net Income(TTM)-6.07M

Analysts42.22

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)26.16%

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	N/A
P/FCF	39.75
P/OCF	39.75
P/B	1.15
P/tB	1.15
EV/EBITDA	N/A

EPS(TTM)-0.11

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)0.04

FCFY2.52%

OCF(TTM)0.04

OCFY2.52%

SpS-0.03

BVpS1.3

TBVpS1.29

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-0.64%
ROE	-0.69%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	-127.4%

ROA(3y)-5.91%

ROA(5y)5.15%

ROE(3y)-5.95%

ROE(5y)5.23%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3Y28.87%

OM growth 5Y16.16%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score5

Asset Turnover-0.02

Health

		Industry Rank	Sector Rank
Debt/Equity	0.03
Debt/FCF	0.89
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	131.7
Quick Ratio	131.7
Altman-Z	8.5

F-Score5

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-161.27%

EPS 3Y-76.41%

EPS 5Y-48.62%

EPS Q2Q%-429.68%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-239.11%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%-1234.63%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-359.1%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y134.7%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y134.7%

OCF growth 3YN/A

OCF growth 5YN/A

SAGA PURE ASA / SAGA.OL FAQ

Can you provide the ChartMill fundamental rating for SAGA PURE ASA?

ChartMill assigns a fundamental rating of 3 / 10 to SAGA.OL.

What is the valuation status of SAGA PURE ASA (SAGA.OL) stock?

ChartMill assigns a valuation rating of 0 / 10 to SAGA PURE ASA (SAGA.OL). This can be considered as Overvalued.

How profitable is SAGA PURE ASA (SAGA.OL) stock?

SAGA PURE ASA (SAGA.OL) has a profitability rating of 1 / 10.

How financially healthy is SAGA PURE ASA?

The financial health rating of SAGA PURE ASA (SAGA.OL) is 9 / 10.

SAGA PURE ASA (SAGA.OL) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

SAGA PURE ASA / SAGA.OL FAQ

Can you provide the ChartMill fundamental rating for SAGA PURE ASA?

What is the valuation status of SAGA PURE ASA (SAGA.OL) stock?

How profitable is SAGA PURE ASA (SAGA.OL) stock?

How financially healthy is SAGA PURE ASA?